Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients

NCT00001474 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Interleukin-2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)